As we emerge from the shadow of COVID-19, it's clear that our global health security remains fragile. As the mpox outbreak continues to spread, the rise of a virus with various strains and modes of transmission has exposed the stark threat that epidemics and pandemics still pose, with antivirals yet to be developed and approved.
The COVID-19 pandemic illustrated that speed is of the essence to limit infections and save lives, necessitating a new approach, and broad-spectrum antivirals could be the game-changer we're looking for. These innovative antivirals offer the potential to combat a wide range of pathogens, including those we have yet to encounter.
Experts project that future respiratory disease epidemics could claim an average of 2.5 million lives globally each year. Even more alarmingly, we could face a pandemic on the scale of COVID-19 or worse every 33 to 50 years, with devastating human and economic impacts.
Collection
[
|
...
]